Replies to post #1299 on Idenix Pharmaceuticals (IDIX)

[go seek]

overreaction... yes
shares are being sold... in some cases to cover.

[dewophile]

"What is telbivudine worth?"

at this point not a whole hell of a lot based on current sales numbers, but that could change. they may do much better in the EU, where cost can play a larger factor given the discount relative to baraclude (and hepsera). in the US my gut tells me idix needs some success in phase IV (particularly in the head to head with entecavir) to capture significant market share

but the discovery engine is worth something